Can Magnetic Resonance Spectroscopy (MRS) detect Alzheimer's disease early?
MRS can signal brain abnormalities in early Alzheimer's disease, but is not yet ready for use as a standalone diagnostic tool. As a complement to PET scanning and other biomarkers the technique is promising, but larger standardised studies are needed before it offers practical benefit to patients.
NAA, a substance that reflects the health of nerve cells, is consistently reduced in the hippocampus and a specific part of the cerebral cortex (the posterior cingulate cortex) in people with early memory complaints as well as in people with Alzheimer's disease. Meta-analyses measure large effect sizes there: in the hippocampus, the difference compared with healthy individuals reaches a Hedges' g of -1.33, which in plain language means that the reduction is substantial and reproducibly measurable. This makes NAA the most consistent MRS marker to date.
Myo-inositol, a substance that rises during inflammation of the brain's support cells, increases in Alzheimer's disease and early memory complaints. What makes this interesting for early detection is that the increase is directly linked to the presence of amyloid-beta plaques in the brain -- the characteristic protein deposits of Alzheimer's disease. Myo-inositol may therefore be able to signal abnormalities before nerve cells are actually lost. The NAA/myo-inositol ratio combines both signals and achieves high specificity in some studies for predicting who will go on to develop Alzheimer's disease. A small post-mortem study confirmed that this ratio is also associated with loss of connections between nerve cells and accumulation of tau protein.
Other brain substances that MRS can measure, such as choline, glutamate and GABA, show a mixed picture. Results contradict each other too often to be reliable at this stage, partly because measurement protocols differ considerably between research centres. One meta-analysis found reduced glutathione levels (an antioxidant) in people with early memory complaints, possibly a sign of oxidative stress, but this has been studied too little to draw any conclusions from it.
The practical bottleneck is that MRS on its own is not specific enough for a definitive Alzheimer's diagnosis. Reviews emphasise that the absence of uniform measurement standards and large long-term studies is blocking the move into clinical practice. The technique holds the most promise as a complement to other investigations, such as a PET scan. Such a combination could help identify for whom further investigation is worthwhile, but this has not yet been validated on a large scale.
Evidence based on three meta-analyses/systematic reviews (PMID 26402632, 23969177, 34751136), multiple reviews (PMID 15853510, 16162090, 18445744) and two other studies (PMID 38427192, 25471565). Associational in nature; no RCTs. No claims are made regarding clinical effectiveness as a validated diagnostic instrument.
Can I test my risk of Alzheimer's with a blood test (p-tau217)?
A p-tau217 blood test can help diagnose Alzheimer's with high accuracy within specialised memory care. Ask your doctor which specific test is being used and whether it meets the quality standards, because not every commercial version reaches the recommended threshold.
Is there a link between oral bacteria and the development of Alzheimer's disease?
There is a consistent association between oral bacteria and Alzheimer's disease, but a proven cause-and-effect relationship in humans has not yet been established. Good oral care is sensible, but do not expect it to offer proven protection against Alzheimer's disease.
Does poor hearing increase my risk of developing dementia?
Poor hearing is associated with a modest but real increased risk of dementia. Have hearing loss assessed and treated promptly, but do not automatically count on direct protection against dementia from a hearing aid.
Does your brain age faster than the rest of your body?
Whether your brain ages faster than the rest of your body varies from person to person, but the consequences are significant: a biologically old brain increases the risk of Alzheimer's more than threefold. Keep an eye on your blood pressure, sleep and lifestyle, as these have the most demonstrable influence on brain ageing.
Does poor sleep cause dementia sooner?
Poor sleep probably increases your risk of dementia, but ordinary insomnia does not make dementia inevitable. One exception: if you physically act out your dreams while sleeping, discuss that with a doctor.
What can I concretely do to prevent dementia?
Various lifestyle choices demonstrably lower your risk, but no single approach guarantees that you will prevent dementia. Regulating blood pressure, exercising, not smoking and staying mentally active are the best-supported steps you can take.